The company
Canopy Growth Corporation - Common Shares
CGC · Nasdaq
CGC stood above a rising 150-day average in 1 of the last 52 weekly readings, and has been out of that trend for the last 51 weeks. It is 28.0% below that average now. Pharmaceuticals: 31% of its 74 stocks in an uptrend (−7 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 51
- Industry in uptrend
- 31% -7 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $788K
- Officials’ trades on record
- 5
- Institutions holding
- 205 (-9)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 1 of 52 weeks.
Pharmaceuticals: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
5 disclosed lines: House 5, Senate 0, executive 0; 2 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| John A. Yarmuth House: U.S. House ClerkKY03 | bought | $1k–$15k | 12 Feb 2021filed 19 Feb 2021 |
| John A. Yarmuth House: U.S. House ClerkKY03 | bought | $1k–$15k | 5 Nov 2020filed 15 Nov 2020 |
| John A. Yarmuth House: U.S. House ClerkKY03 | bought | $1k–$15k | 10 Mar 2020filed 11 Aug 2021 |
| John A. Yarmuth House: U.S. House ClerkKY03 | sold | $1k–$15k | 10 Mar 2020filed 2 May 2020 |
| Brenda L. Lawrence House: U.S. House ClerkMI14 | bought | $1k–$15k | 23 Oct 2018filed 21 Aug 2019 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| M. Shan AtkinsDirector | sold | 3,096at $0.9268 | 28 Sep 2026filed 30 Sep 2026 |
| Joseph BayernDirector | sold | 3,096at $0.9268 | 28 Sep 2026filed 30 Sep 2026 |
| David Angelo LazzaratoDirector | sold | 22,380at $0.9268 | 28 Sep 2026filed 30 Sep 2026 |
| Theresa YanofskyDirector | sold | 14,920at $0.9268 | 28 Sep 2026filed 30 Sep 2026 |
| Thomas Carlton StewartOfficer | sold | 25,755at $0.93 | 17 Sep 2026filed 17 Sep 2026 |
| Thomas Carlton StewartOfficer | sold | 2,231at $1.47 | 24 Aug 2026filed 25 Aug 2026 |
| Christelle GedeonOfficer | sold | 13,344at $1.47 | 24 Aug 2026filed 25 Aug 2026 |
| David Angelo LazzaratoDirector | sold | 22,674at $0.9237 | 26 Jun 2026filed 29 Jun 2026 |
| M. Shan AtkinsDirector | sold | 3,197at $0.9237 | 26 Jun 2026filed 29 Jun 2026 |
| Theresa YanofskyDirector | sold | 15,054at $0.9237 | 26 Jun 2026filed 29 Jun 2026 |
| Joseph BayernDirector | sold | 3,197at $0.9237 | 26 Jun 2026filed 29 Jun 2026 |
| Luc MongeauChief Executive Officer | sold | 135,231at $0.9741 | 17 Jun 2026filed 22 Jun 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| Tidal Investments LLCadded · filed 13 Aug 2026 | 9,189,630$8.7M | +709,737+8.4% |
| MORGAN STANLEYreduced · filed 13 Aug 2026 | 1,946,294$1.8M | -23,346−1.2% |
| LAZARD ASSET MANAGEMENT LLCadded · filed 14 Aug 2026 | 1,847,500$1.8M | +39,514+2.2% |
| JANE STREET GROUP, LLCreduced · filed 14 Aug 2026 | 1,562,808$1.5M | -19,504−1.2% |
| UBS Group AGadded · filed 13 Aug 2026 | 1,396,338$1.3M | +456,939+48.6% |
| GOLDMAN SACHS GROUP INCadded · filed 14 Aug 2026 | 1,303,720$1.2M | +40,118+3.2% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLPadded · filed 14 Aug 2026 | 1,219,106$1.2M | +238,530+24.3% |
| ROYAL BANK OF CANADAadded · filed 14 Aug 2026 | 1,081,963$1.0M | +105,996+10.9% |
| NATIONAL BANK OF CANADAadded · filed 10 Aug 2026 | 858,456$816K | +48,465+6.0% |
| Sullivan Wood Capital Management LLCreduced · filed 22 Jul 2026 | 690,585$656K | -163,700−19.2% |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.